Andrew L. Frelinger
Boston University(US)Boston Medical Center(US)Boston Children's Hospital(US)Harvard University(US)Platelet BioGenesis (United States)(US)Boston Children's Museum(US)Dana-Farber/Boston Children's Cancer and Blood Disorders Center(US)
Publications by Year
Research Areas
Platelet Disorders and Treatments, Antiplatelet Therapy and Cardiovascular Diseases, Venous Thromboembolism Diagnosis and Management, Acute Myocardial Infarction Research, Blood groups and transfusion
Most-Cited Works
- → Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention(2007)875 cited
- → Ligands “activate” integrin αIIbβ3 (platelet GPIIb-IIIa)(1991)490 cited
- → A β 3 Integrin Mutation Abolishes Ligand Binding and Alters Divalent Cation-Dependent Conformation(1990)410 cited
- → Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction(2001)405 cited
- → Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease(2011)375 cited
- → Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function.(1991)359 cited